The nurse is caring for a patient receiving IV acyclovir. To ...

[saliriagwu]

The nurse is caring for a patient receiving IV acyclovir. To prevent nephrotoxicity associated with intravenous acyclovir, the nurse would do which of the following?
 
  a. Provide a low-protein diet for 1 day before and 2 days after the acyclovir infu-sion.
  b. Infuse IV fluids during and for 2 hours after the acyclovir infusion.
  c. Increase the patient's intake of vitamin C rich foods.
  d. Monitor urinary output every 30 minutes.

Question 2

A nurse working in a private pediatric practice is caring for a patient who has been receiving 17alpha-alkylated androgen (Fluoxymesterone).
 
  Which clinical manifestation would cause the nurse to be concerned, and what intervention would the nurse anticipate? a. Gynecomastia; discontinuation of the drug
  b. Yellowish tint to the skin and sclera; discontinuation of the drug
  c. Decrease in high-density lipoprotein (HDL); titration of the medication
  d. Erratic blood glucose levels; adjustment of the dose

[amy.lauersdorf90]

Answer to Question 1

B
The nurse should include the infusion of IV fluids during and for 2 hours after the acyclovir in-fusion to prevent nephrotoxicity by perfusing the kidneys.
A low-protein diet is not indicted after an acyclovir infusion.
Increasing vitamin C would not help prevent nephrotoxicity.
Monitoring urine output is important but would not help prevent nephrotoxicity.

Answer to Question 2

B
A yellowish tint to the skin and sclera would most concern the nurse, because 17alpha-alkylated androgen (Fluoxymesterone) is known to cause hepatotoxicity.
Gynecomastia is expected in males.
A decrease in HDL would require monitoring of those levels but not titration of the medication.
Fluoxymesterone is not associated with erratic blood glucose levels.

[saliriagwu]

Gracias!

[bigcheese9]

Thanks for the timely response, appreciate it